Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen McNicholas

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 16, 2016
Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trialMelody Y Hou, Colleen McNicholas, Mitchell D Creinin
Contraception|July 2, 2016
Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system useManuela Mejia, Colleen McNicholas, Tessa Madden, et al.
American Journal of Obstetrics and Gynecology|February 2, 2017
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved durationColleen McNicholas, Erin Swor, Leping Wan, et al.
Clinical Obstetrics and Gynecology|October 7, 2014
The contraceptive CHOICE project round up: what we did and what we learnedColleen McNicholas, Tessa Madden, Gina Secura, et al.
Obstetrics and Gynecology|August 11, 2017
Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE ProjectAbigail Iseyemi, Qiuhong Zhao, Colleen McNicholas, et al.
Obstetrics and Gynecology|March 3, 2015
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved durationColleen McNicholas, Ragini Maddipati, Qiuhong Zhao, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|July 16, 2021
Differences in Financial and Social Burdens Experienced by Patients Traveling for Abortion CareAmy N Addante, Rachel Paul, Megan Dorsey, et al.
Obstetrics and Gynecology|August 22, 2018
Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled TrialRachel E Zigler, Tessa Madden, Caitlin Ashby, et al.
American Journal of Obstetrics and Gynecology|January 6, 2009
Douching and the risk for sexually transmitted disease: Tsai et alJenifer E Allsworth, Katherine J Hladky, Taylor Hotchkiss, et al.
Open Access Journal of Contraception|February 2, 2018
Long-acting reversible contraception use among residents in obstetrics/gynecology training programsRachel E Zigler, Jeffrey F Peipert, Qiuhong Zhao, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 16, 2016
Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trialMelody Y Hou, Colleen McNicholas, Mitchell D Creinin
Contraception|July 2, 2016
Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system useManuela Mejia, Colleen McNicholas, Tessa Madden, et al.
American Journal of Obstetrics and Gynecology|February 2, 2017
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved durationColleen McNicholas, Erin Swor, Leping Wan, et al.
Clinical Obstetrics and Gynecology|October 7, 2014
The contraceptive CHOICE project round up: what we did and what we learnedColleen McNicholas, Tessa Madden, Gina Secura, et al.
Obstetrics and Gynecology|August 11, 2017
Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE ProjectAbigail Iseyemi, Qiuhong Zhao, Colleen McNicholas, et al.
Obstetrics and Gynecology|March 3, 2015
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved durationColleen McNicholas, Ragini Maddipati, Qiuhong Zhao, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|July 16, 2021
Differences in Financial and Social Burdens Experienced by Patients Traveling for Abortion CareAmy N Addante, Rachel Paul, Megan Dorsey, et al.
Obstetrics and Gynecology|August 22, 2018
Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled TrialRachel E Zigler, Tessa Madden, Caitlin Ashby, et al.
American Journal of Obstetrics and Gynecology|January 6, 2009
Douching and the risk for sexually transmitted disease: Tsai et alJenifer E Allsworth, Katherine J Hladky, Taylor Hotchkiss, et al.
Open Access Journal of Contraception|February 2, 2018
Long-acting reversible contraception use among residents in obstetrics/gynecology training programsRachel E Zigler, Jeffrey F Peipert, Qiuhong Zhao, et al.
Pageof 4